Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc.

TRGM - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$302
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Targeted Medical Pharma, Inc.Targeted Medical Pharma, Inc.0-24%--0.4

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$302.00
Enterprise Value$5.21 Million
Earnings per Share$-0.11
Beta0.03
Outstanding Shares27,218,049

Return

Return on Equity23.60%ROE
Return on Assets-125.41%
Return on Invested Capital15.46%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue0.99
Enterprise Value to EBIT-2.75
Enterprise Value to Net Income-2
Total Debt to Enterprise1.02
Debt to Equity-0.41Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Targeted Medical Pharma, Inc.

30 employees
CEO: Cameron Tymstra

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers...

Questions & Answers